サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1434617

アレルギー性鼻炎治療薬市場：投与経路、薬剤クラス別、用途別-2024～2030年の世界予測

Allergic Rhinitis Drugs Market by Route of Administration (Intranasal, Intraocular, Oral), Class of Drugs (Antihistamines, Immunotherapies, Intranasal Corticosteroids), Application - Global Forecast 2024-2030
出版日: | 発行: 360iResearch | ページ情報: 英文 194 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
アレルギー性鼻炎治療薬市場：投与経路、薬剤クラス別、用途別-2024～2030年の世界予測
出版日: 2024年01月15日
発行: 360iResearch
ページ情報: 英文 194 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

アレルギー性鼻炎治療薬市場規模は2023年に47億5,000万米ドルと推計され、2024年には49億7,000万米ドルに達し、CAGR 4.77%で2030年には65億9,000万米ドルに達すると予測されます。

アレルギー性鼻炎治療薬の世界市場

主な市場の統計
基準年[2023］ 47億5,000万米ドル
予測年[2024］ 49億7,000万米ドル
予測年 [2030] 65億9,000万米ドル
CAGR（%） 4.77%
アレルギー性鼻炎治療薬 Market-IMG1

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスはアレルギー性鼻炎治療薬市場を評価する上で極めて重要です。事業戦略と製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析は、アレルギー性鼻炎治療薬市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1-市場の浸透度：主要企業が提供する市場に関する包括的な情報を提示しています。

2-市場の開拓度：有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3-市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4-競合の評価と情報：市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力などを網羅的に評価します。

5-製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています：

1-アレルギー性鼻炎治療薬市場の市場規模および予測は？

2-アレルギー性鼻炎治療薬市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か？

3-アレルギー性鼻炎治療薬市場における技術動向と規制の枠組みは？

4-アレルギー性鼻炎治療薬市場における主要ベンダーの市場シェアは？

5-アレルギー性鼻炎治療薬市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • アレルギー性鼻炎の有病率の上昇
      • 喫煙増加によるライフスタイルの変化がアレルギー性鼻炎を促進
      • 点鼻薬などのさまざまな投与方法が利用できるようになり、アレルギー性鼻炎治療薬の需要が増加
      • 市販薬の需要
    • 抑制要因
      • アレルギー性鼻炎の症状の特異性の低下
    • 機会
      • アレルギー性鼻炎治療薬の開発と商品化の拡大
      • アレルギー性鼻炎に対する認識を高めるための政府および組織の取り組みの強化
    • 課題
      • アレルギー性鼻炎には標準的な治療法はない
  • 市場セグメンテーション分析
  • 市場動向分析
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み

第6章 アレルギー性鼻炎治療薬市場：投与経路別

  • 鼻腔内
  • 眼内
  • オーラル
  • 非経口

第7章 アレルギー性鼻炎治療薬市場薬物のクラス別

  • 抗ヒスタミン薬
  • 免疫療法
  • 鼻腔内コルチコステロイド

第8章 アレルギー性鼻炎治療薬市場：用途別

  • 病院薬局
  • オンライン薬局
  • 小売薬局

第9章 南北アメリカのアレルギー性鼻炎治療薬市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第10章 アジア太平洋地域のアレルギー性鼻炎治療薬市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第11章 欧州・中東・アフリカのアレルギー性鼻炎治療薬市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第12章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析：主要企業別
  • 競合シナリオ主要企業別の分析

第13章 競争力のあるポートフォリオ

  • 主要な企業プロファイル
    • Adamis Pharmaceuticals
    • Alcon, Inc.
    • Apotex Inc.
    • Ascend Laboratories LLC by The Pharma Network, LLC
    • Dr. Reddy's Laboratories, Ltd.
    • Gland Pharma Limited
    • GlaxoSmithKline PLC
    • Hikma Pharmaceuticals PLC
    • Johnson & Johnson Services, Inc.
    • Merck & Co., Inc.
    • Mitsubishi Tanabe Pharma Corporation
    • Sandoz International GmbH by Novartis AG
    • Sun Pharmaceutical Industries Ltd.
    • Teva Pharmaceutical Industries Ltd.
    • Unichem Laboratories Ltd.
  • 主要な製品ポートフォリオ

第14章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. ALLERGIC RHINITIS DRUGS MARKET RESEARCH PROCESS
  • FIGURE 2. ALLERGIC RHINITIS DRUGS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. ALLERGIC RHINITIS DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. ALLERGIC RHINITIS DRUGS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. ALLERGIC RHINITIS DRUGS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. ALLERGIC RHINITIS DRUGS MARKET DYNAMICS
  • FIGURE 7. ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
  • FIGURE 8. ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2023 VS 2030 (%)
  • FIGURE 10. ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 12. ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS ALLERGIC RHINITIS DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS ALLERGIC RHINITIS DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES ALLERGIC RHINITIS DRUGS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES ALLERGIC RHINITIS DRUGS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC ALLERGIC RHINITIS DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC ALLERGIC RHINITIS DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. ALLERGIC RHINITIS DRUGS MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 22. ALLERGIC RHINITIS DRUGS MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. ALLERGIC RHINITIS DRUGS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. ALLERGIC RHINITIS DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ALLERGIC RHINITIS DRUGS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 6. ALLERGIC RHINITIS DRUGS MARKET SIZE, BY INTRANASAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. ALLERGIC RHINITIS DRUGS MARKET SIZE, BY INTRAOCULAR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. ALLERGIC RHINITIS DRUGS MARKET SIZE, BY PARENTERAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
  • TABLE 11. ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ANTIHISTAMINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. ALLERGIC RHINITIS DRUGS MARKET SIZE, BY IMMUNOTHERAPIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. ALLERGIC RHINITIS DRUGS MARKET SIZE, BY INTRANASAL CORTICOSTEROIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 15. ALLERGIC RHINITIS DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. ALLERGIC RHINITIS DRUGS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS ALLERGIC RHINITIS DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. MEXICO ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES ALLERGIC RHINITIS DRUGS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 38. ASIA-PACIFIC ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC ALLERGIC RHINITIS DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 42. AUSTRALIA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. CHINA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. INDIA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. INDONESIA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. JAPAN ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. MALAYSIA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. PHILIPPINES ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. SINGAPORE ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. SOUTH KOREA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. TAIWAN ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. THAILAND ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. VIETNAM ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 82. DENMARK ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. EGYPT ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. FINLAND ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. FRANCE ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. GERMANY ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. ISRAEL ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. ITALY ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. NETHERLANDS ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. NIGERIA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. NORWAY ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. POLAND ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. QATAR ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. RUSSIA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 121. SAUDI ARABIA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH AFRICA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. SPAIN ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. SWEDEN ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. SWITZERLAND ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. TURKEY ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED ARAB EMIRATES ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED KINGDOM ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 145. ALLERGIC RHINITIS DRUGS MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 146. ALLERGIC RHINITIS DRUGS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 147. ALLERGIC RHINITIS DRUGS MARKET LICENSE & PRICING
目次
Product Code: MRR-436901065A1E

[194 Pages Report] The Allergic Rhinitis Drugs Market size was estimated at USD 4.75 billion in 2023 and expected to reach USD 4.97 billion in 2024, at a CAGR 4.77% to reach USD 6.59 billion by 2030.

Global Allergic Rhinitis Drugs Market

KEY MARKET STATISTICS
Base Year [2023] USD 4.75 billion
Estimated Year [2024] USD 4.97 billion
Forecast Year [2030] USD 6.59 billion
CAGR (%) 4.77%
Allergic Rhinitis Drugs Market - IMG1

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Allergic Rhinitis Drugs Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Allergic Rhinitis Drugs Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Allergic Rhinitis Drugs Market, highlighting leading vendors and their innovative profiles. These include Adamis Pharmaceuticals, Alcon, Inc., Apotex Inc., Ascend Laboratories LLC by The Pharma Network, LLC, Dr. Reddy's Laboratories, Ltd., Gland Pharma Limited, GlaxoSmithKline PLC, Hikma Pharmaceuticals PLC, Johnson & Johnson Services, Inc., Merck & Co., Inc., Mitsubishi Tanabe Pharma Corporation, Sandoz International GmbH by Novartis AG, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., and Unichem Laboratories Ltd..

Market Segmentation & Coverage

This research report categorizes the Allergic Rhinitis Drugs Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Route of Administration
    • Intranasal
    • Intraocular
    • Oral
    • Parenteral
  • Class of Drugs
    • Antihistamines
    • Immunotherapies
    • Intranasal Corticosteroids
  • Application
    • Hospital Pharmacy
    • Online Pharmacy
    • Retail Pharmacy
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Allergic Rhinitis Drugs Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Allergic Rhinitis Drugs Market?

3. What are the technology trends and regulatory frameworks in the Allergic Rhinitis Drugs Market?

4. What is the market share of the leading vendors in the Allergic Rhinitis Drugs Market?

5. Which modes and strategic moves are suitable for entering the Allergic Rhinitis Drugs Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Allergic Rhinitis Drugs Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of allergic rhinitis
      • 5.1.1.2. Increasing lifestyle changes attributes to growing use of tobacco promotes allergic rhinitis
      • 5.1.1.3. Availability of different modes of administration such as nasal sprays increases demand for allergic rhinitis drugs
      • 5.1.1.4. Demand for over-the-counter drugs
    • 5.1.2. Restraints
      • 5.1.2.1. Reduced specificity of symptoms for allergic rhinitis
    • 5.1.3. Opportunities
      • 5.1.3.1. Growing development and commercialization of allergic rhinitis drugs
      • 5.1.3.2. Increasing government and organization initiatives to increase the awareness of allergic rhinitis
    • 5.1.4. Challenges
      • 5.1.4.1. No standard cure for allergic rhinitis
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Allergic Rhinitis Drugs Market, by Route of Administration

  • 6.1. Introduction
  • 6.2. Intranasal
  • 6.3. Intraocular
  • 6.4. Oral
  • 6.5. Parenteral

7. Allergic Rhinitis Drugs Market, by Class of Drugs

  • 7.1. Introduction
  • 7.2. Antihistamines
  • 7.3. Immunotherapies
  • 7.4. Intranasal Corticosteroids

8. Allergic Rhinitis Drugs Market, by Application

  • 8.1. Introduction
  • 8.2. Hospital Pharmacy
  • 8.3. Online Pharmacy
  • 8.4. Retail Pharmacy

9. Americas Allergic Rhinitis Drugs Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Allergic Rhinitis Drugs Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Allergic Rhinitis Drugs Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
  • 12.2. Market Share Analysis, By Key Player
  • 12.3. Competitive Scenario Analysis, By Key Player

13. Competitive Portfolio

  • 13.1. Key Company Profiles
    • 13.1.1. Adamis Pharmaceuticals
    • 13.1.2. Alcon, Inc.
    • 13.1.3. Apotex Inc.
    • 13.1.4. Ascend Laboratories LLC by The Pharma Network, LLC
    • 13.1.5. Dr. Reddy's Laboratories, Ltd.
    • 13.1.6. Gland Pharma Limited
    • 13.1.7. GlaxoSmithKline PLC
    • 13.1.8. Hikma Pharmaceuticals PLC
    • 13.1.9. Johnson & Johnson Services, Inc.
    • 13.1.10. Merck & Co., Inc.
    • 13.1.11. Mitsubishi Tanabe Pharma Corporation
    • 13.1.12. Sandoz International GmbH by Novartis AG
    • 13.1.13. Sun Pharmaceutical Industries Ltd.
    • 13.1.14. Teva Pharmaceutical Industries Ltd.
    • 13.1.15. Unichem Laboratories Ltd.
  • 13.2. Key Product Portfolio

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing